“…In particular, miR-21 targets multiple genes in mTOR pathway, including PTEN, p85α and PDCD4. Besides promoting malignant growth, the miR-21/PTEN/PI3K/AKT/mTOR axis has been shown to influence anti-cancer effects of zoledronic acid [80] , triptolide [81] , Metformin [82] , Matrine [83] and curcumin [84] , and modulate radiosensitivity [85, 86] and chemosensitivity to tamoxifen, fulvestrant [87] , sorafenib [88] , cisplatin [89, 90] , imatinib [91] , gefitinib [92] , doxorubicin [93] , daunorubicin [94] , anti-EGFR tyrosine kinase inhibitors (TKI) [95] and the CHOP chemotherapy regimen [96] . miR-21 also influences PI3K/AKT/mTOR signaling via PIK3R1 that negatively regulates p110 subunit under certain circumstances.…”